- Home
- MDIA vs ATYR Comparison
MDIA vs ATYR Comparison
Compare MDIA & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- ATYR
- Stock Information
- Founded
- MDIA 2019
- ATYR 2005
- Country
- MDIA United States
- ATYR United States
- Employees
- MDIA N/A
- ATYR N/A
- Industry
- MDIA Broadcasting
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDIA Consumer Discretionary
- ATYR Health Care
- Exchange
- MDIA Nasdaq
- ATYR Nasdaq
- Market Cap
- MDIA 102.4M
- ATYR 86.3M
- IPO Year
- MDIA N/A
- ATYR 2015
- Fundamental
- Price
- MDIA $0.92
- ATYR $0.79
- Analyst Decision
- MDIA
- ATYR Buy
- Analyst Count
- MDIA 0
- ATYR 6
- Target Price
- MDIA N/A
- ATYR $8.75
- AVG Volume (30 Days)
- MDIA 32.3K
- ATYR 4.5M
- Earning Date
- MDIA 11-13-2025
- ATYR 11-06-2025
- Dividend Yield
- MDIA N/A
- ATYR N/A
- EPS Growth
- MDIA N/A
- ATYR N/A
- EPS
- MDIA 0.40
- ATYR N/A
- Revenue
- MDIA $121,938,000.00
- ATYR $190,000.00
- Revenue This Year
- MDIA N/A
- ATYR $420.85
- Revenue Next Year
- MDIA N/A
- ATYR $1,513.40
- P/E Ratio
- MDIA $2.35
- ATYR N/A
- Revenue Growth
- MDIA 165.75
- ATYR N/A
- 52 Week Low
- MDIA $0.79
- ATYR $0.68
- 52 Week High
- MDIA $1.90
- ATYR $7.29
- Technical
- Relative Strength Index (RSI)
- MDIA 18.42
- ATYR 28.30
- Support Level
- MDIA $0.93
- ATYR $0.74
- Resistance Level
- MDIA $1.12
- ATYR $0.84
- Average True Range (ATR)
- MDIA 0.05
- ATYR 0.05
- MACD
- MDIA -0.02
- ATYR 0.05
- Stochastic Oscillator
- MDIA 2.86
- ATYR 17.06
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.